Commonwealth Equity Services LLC lifted its position in DaVita Inc. (NYSE:DVA – Free Report) by 48.4% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,997 shares of the company’s stock after buying an additional 12,726 shares during the period. Commonwealth Equity Services LLC’s holdings in DaVita were worth $3,163,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Te Ahumairangi Investment Management Ltd raised its position in shares of DaVita by 3.5% during the first quarter. Te Ahumairangi Investment Management Ltd now owns 111,990 shares of the company’s stock worth $9,084,000 after purchasing an additional 3,805 shares during the period. Private Advisor Group LLC bought a new stake in DaVita during the 1st quarter worth approximately $348,000. Vanguard Personalized Indexing Management LLC raised its holdings in DaVita by 10.9% during the 1st quarter. Vanguard Personalized Indexing Management LLC now owns 3,202 shares of the company’s stock worth $260,000 after buying an additional 315 shares during the period. MAI Capital Management lifted its stake in DaVita by 59.0% in the first quarter. MAI Capital Management now owns 5,045 shares of the company’s stock valued at $409,000 after buying an additional 1,873 shares in the last quarter. Finally, Bessemer Group Inc. boosted its holdings in shares of DaVita by 55.1% in the first quarter. Bessemer Group Inc. now owns 445 shares of the company’s stock valued at $36,000 after buying an additional 158 shares during the period. 84.69% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several research firms recently commented on DVA. UBS Group raised shares of DaVita from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $100.00 to $142.00 in a research report on Monday, August 7th. Truist Financial lifted their target price on DaVita from $100.00 to $115.00 and gave the company a “hold” rating in a research report on Thursday, July 13th. StockNews.com raised DaVita from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, August 16th. Sanford C. Bernstein boosted their price objective on shares of DaVita from $88.00 to $100.00 in a research report on Monday, May 15th. Finally, Bank of America lifted their price target on shares of DaVita from $86.00 to $96.00 in a research note on Tuesday, May 9th. Four research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, DaVita presently has a consensus rating of “Moderate Buy” and a consensus target price of $105.29.
DaVita Trading Up 0.6 %
DaVita stock opened at $102.99 on Tuesday. The stock has a 50-day simple moving average of $103.04 and a 200 day simple moving average of $93.19. The stock has a market capitalization of $9.40 billion, a P/E ratio of 20.48, a PEG ratio of 1.13 and a beta of 0.94. The company has a debt-to-equity ratio of 7.13, a quick ratio of 1.20 and a current ratio of 1.25. DaVita Inc. has a 52 week low of $65.28 and a 52 week high of $116.97.
DaVita (NYSE:DVA – Get Free Report) last issued its earnings results on Thursday, August 3rd. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $1.66 by $0.42. DaVita had a return on equity of 60.67% and a net margin of 3.98%. The company had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.95 billion. During the same period in the previous year, the company posted $2.30 EPS. The firm’s revenue for the quarter was up 2.5% compared to the same quarter last year. Analysts expect that DaVita Inc. will post 7.22 earnings per share for the current year.
Insider Activity
In related news, insider Kathleen Alyce Waters sold 9,794 shares of DaVita stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $101.81, for a total transaction of $997,127.14. Following the completion of the sale, the insider now owns 81,297 shares of the company’s stock, valued at approximately $8,276,847.57. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.40% of the company’s stock.
DaVita Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Articles
- Five stocks we like better than DaVita
- Are Penny Stocks a Good Fit for Your Portfolio?
- MarketBeat Week in Review – 8/28 – 9/1
- 3 Tickers Leading a Meme Stock Revival
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- What Are Dividend Champions? How to Invest in the Champions
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.
